IO Biotech GAAP EPS of -$0.40

1 hour ago 1

IO Biotech press release (NASDAQ:IOBT): Q2 GAAP EPS of -$0.40.
Cash and cash equivalents as of June 30, 2025 were $28.1 million, compared to $60.0 million at December 31, 2024. During the three months ended June 30, 2025, the company used cash, cash equivalents and restricted cash of $9.0 million. The

Recommended For You